TOPPER IAS
Login Talk to a mentor

← 3 October 2026's Current Affairs · Science & Tech GA Prelims ★★★★☆ Mains ★★☆☆☆

CSIR-CCMB Develops India-Specific Tool to Predict Sickle Cell Severity

3 October 2026 · ⏱ 2 ମିନିଟ · GS-III Science & Technology — Biotechnology and health

1

ଖବରରେ କାହିଁକି?

Why one beta-globin mutation causes sickle cell, and what CSIR-CCMB's India-specific severity tool changes for GS-III

CSIR-CCMB's new tool predicts sickle cell severity in Indian patients.

Why it matters: factual, Prelims-type

CSIR-CCMB Develops India-Specific Tool to Predict Sickle Cell Severity
SpicyMilkBoy · CC BY-SA 4.0 · Wikimedia Commons
2

What you need to know

2 ମିନିଟ

Scientists at CSIR-CCMB have developed an India-specific tool to predict the severity of sickle cell anaemia.

Existing international scoring systems do not accurately reflect the clinical profile of Indian patients, and the new tool could improve treatment decisions and disease management.

ଉତ୍ସ: Topper IAS editorial (PIB / The Hindu / Indian Express)

3

ମୁଖ୍ୟ ତଥ୍ୟ

Remember these

  • CSIR-CCMB (Hyderabad) has developed an India-specific tool to predict sickle cell anaemia severity.
  • Existing international severity scores do not reflect the clinical profile of Indian patients.
  • Sickle cell anaemia is caused by a point mutation in the beta-globin gene (HBB), producing haemoglobin S.
  • It is an autosomal recessive disorder; carriers (sickle cell trait) are usually asymptomatic.
  • CCMB, the Centre for Cellular and Molecular Biology, is a CSIR laboratory.
4

ପ୍ରିଲିମ୍ସ · ମେନ୍ସ

How the exam will ask it

ପ୍ରିଲିମ୍ସ

  • Sickle cell anaemia results from a mutation in the beta-globin gene, not the alpha-globin gene.
  • Sickle cell anaemia is an inherited autosomal recessive disorder of haemoglobin.
  • CSIR-CCMB is a constituent laboratory of the Council of Scientific and Industrial Research and is located in Hyderabad.

ମେନ୍ସ

GS-III Science & Technology and GS-II Health. Issue: international sickle cell severity scores do not fit Indian patients, whose clinical profile differs. Policy: a locally validated predictive tool supports better treatment decisions within national efforts against the disease. Implication: better risk stratification and disease management; way forward: validate the tool across regions and integrate it with screening and tribal health programmes.

5

Quick recall

Answer before you reveal

Sickle cell anaemia is an inherited blood disorder caused by a mutation in the gene that codes for which part of haemoglobin?

  1. Alpha-globin chain
  2. Beta-globin chain
  3. Gamma-globin chain
  4. Delta-globin chain
ଉତ୍ତର ଦେଖନ୍ତୁ

ଉତ୍ତର: B — Correct: Beta-globin chain — Sickle cell anaemia results from a point mutation in the beta-globin gene (HBB), producing abnormal haemoglobin S. • Alpha-globin chain — wrong: Alpha-globin gene changes cause alpha-thalassaemia, not sickle cell anaemia. • Gamma-globin chain — wrong: Gamma-globin makes up foetal haemoglobin and is not the site of the sickle cell mutation. • Delta-globin chain — wrong: Delta-globin forms the minor adult haemoglobin A2 and is not the site of the sickle cell mutation.

6

Convert this topic into marks

Today's 10-MCQ test · instant analysis · Powered by AdaptIQ

DONE READING?

Test today's current affairs.